Innerwell is a psychedelic telehealth platform offering at-home ketamine therapy combined with licensed therapist support. It emphasizes therapeutic relationships and integration alongside medication.
Innerwell is a telemedicine mental health platform specializing in innovative treatment modalities including ketamine-assisted therapy, psychedelic integration, EMDR, and traditional psychiatry/psychotherapy. The company operates across 33 US states, offering personalized treatment programs through a network of licensed psychiatrists, psychiatric nurse practitioners, and licensed psychotherapists. Their integrated digital platform combines medication management, therapy sessions, mood tracking, and specialized treatment protocols in a unified app-based care delivery system, with 87% of patients reporting improvements in depression and anxiety within 4 weeks.
